Aladdin Healthcare Technologies SE
ALDNF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | 0.07 | -0.00 | 3.39 |
| FCF Yield | -11.00% | -18.82% | -61.21% | -0.33% |
| EV / EBITDA | -6.70 | -60.12 | -3.69 | -1.70 |
| Quality | ||||
| ROIC | 981.83% | 838.91% | -97.87% | -0.38% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 0.00% |
| Cash Conversion Ratio | 0.48 | 0.53 | 0.64 | 0.81 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | – | – | -100.00% |
| Free Cash Flow Growth | 60.74% | 55.12% | -18,577.25% | 78.13% |
| Safety | ||||
| Net Debt / EBITDA | -1.89 | -8.35 | 0.06 | 247.20 |
| Interest Coverage | -11.40 | -23.70 | -190.37 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -4,976.22 | -59,169.52 | 0.00 | 0.00 |